ALX ONCOLOGY HOLDINGS INC. - COMMON STOCK
0.8379
14-3月-25 15:31:07
15 分の遅延
株式
+0.0065
+0.78%
本日の幅
0.8300 - 0.8600
ISIN
N/A
ソース
NASDAQ
-
ALX Oncology Realigns Executive Leadership Team
06 9 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
ALX Oncology Announces September Investor Conference Participation
31 8 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
ALX Oncology Reports Second Quarter 2023 Financial Results and Provides Clinical Program Update
10 8 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
26 6 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
11 5 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
09 5 2023 07:00:02 提供 Nasdaq GlobeNewswire
-
25 4 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
13 3 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
09 3 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
16 2 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2023
05 1 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
ALX Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 1 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
ALX Oncology Appoints Scott Garland to its Board of Directors
29 11 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
08 11 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
03 11 2022 09:00:01 提供 Nasdaq GlobeNewswire
-
ALX Oncology Announces Upcoming Investor Conference Participation
02 11 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
31 10 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
05 10 2022 08:01:00 提供 Nasdaq GlobeNewswire
-
ALX Oncology to Participate in the Cantor Oncology, Hematology & HemeOnc Conference
21 9 2022 16:01:00 提供 Nasdaq GlobeNewswire